Papers/PMID:35979259
Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation.
World journal of gastroenterology2022The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
Saccharomyces cerevisiae — no detected effect on stool frequency
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The bowel movement frequency and BSS scores increased in Probiotic and Placebo groups between W0 and W8 (P < 0.01 from W1 to W8), but no statistically significant differences were found between the groups.”
Quoted verbatim from Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 8 x 10^9 CFU daily in two 500 mg capsules
- Population
- Adults with irritable bowel syndrome with predominant constipation (Rome IV); 8 weeks of supplementation
Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation.2022PMID:35979259An author is affiliated with a producerPermalink